Ondine Biomedical, Inc.'s market cap is currently £48.48M. The company's EPS TTM is p-0.037; its P/E ratio is ―; Ondine Biomedical, Inc. is scheduled to report earnings on May 15, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	C$ 1.20M	C$ 638.00K	C$ 2.57M	C$ 1.79M	C$ 464.00K
Gross Profit	C$ 703.00K	C$ 287.00K	C$ 1.25M	C$ 649.00K	C$ 136.00K
Operating Income	C$ -14.80M	C$ -18.76M	C$ -17.52M	C$ -15.87M	C$ -14.03M
EBITDA	C$ -13.79M	C$ -18.85M	C$ -16.84M	C$ -14.56M	C$ -12.59M
Net Income	C$ -14.41M	C$ -20.78M	C$ -82.82M	C$ -16.92M	C$ -14.16M
Balance Sheet
Cash & Short-Term Investments	C$ 2.98M	C$ 13.13M	C$ 30.36M	C$ 626.00K	C$ 306.00K
Total Assets	C$ 5.73M	C$ 16.57M	C$ 34.14M	C$ 2.63M	C$ 2.91M
Total Debt	C$ 541.00K	C$ 896.00K	C$ 739.00K	C$ 31.46M	C$ 28.04M
Net Debt	C$ -2.44M	C$ -12.23M	C$ -29.63M	C$ 30.83M	C$ 27.74M
Total Liabilities	C$ 3.65M	C$ 4.92M	C$ 4.48M	C$ 36.46M	C$ 28.99M
Stockholders' Equity	C$ 2.08M	C$ 11.64M	C$ 29.66M	C$ -33.81M	C$ -26.06M
Cash Flow
Free Cash Flow	C$ -13.83M	C$ -16.66M	C$ -12.62M	C$ -6.43M	C$ -7.58M
Operating Cash Flow	C$ -13.65M	C$ -16.34M	C$ -12.54M	C$ -6.33M	C$ -7.55M
Investing Cash Flow	C$ -177.00K	C$ -311.00K	C$ -77.00K	C$ 2.90M	C$ -33.00K
Financing Cash Flow	C$ 3.79M	C$ -275.00K	C$ 41.90M	C$ 3.83M	C$ 6.58M

Currency in CAD

Ondine Biomedical, Inc. Earnings and Revenue History

Income Statement >

Ondine Biomedical, Inc. Debt to Assets

Balance Sheet >

Ondine Biomedical, Inc. Cash Flow

Cash Flow >

Ondine Biomedical, Inc. Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing